BCM
EHC icon

Bayesian Capital Management’s Encompass Health EHC Stock Holding History

Bayesian Capital Management’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,635
Closed -$462K – 251
2025
Q3 		$462K Sell
3,635
-16,869
-82% -$2.01M 0.09% 294
2025
Q2 		$2.51M Buy
+20,504
New +$2.34M 0.4% 64
2025
Q1 		– Sell
-7,475
Closed -$690K – 706
2024
Q4 		$690K Buy
+7,475
New +$734K 0.08% 307
2024
Q1 		– Sell
-7,000
Closed -$467K – 863
2023
Q4 		$467K Sell
7,000
-3,400
-33% -$220K 0.05% 400
2023
Q3 		$698K Sell
10,400
-3,100
-23% -$213K 0.08% 290
2023
Q2 		$914K Hold
13,500
– – 0.1% 275
2023
Q1 		$730K Buy
+13,500
New +$786K 0.09% 298
2022
Q2 		– Sell
-4,274
Closed -$242K – 854
2022
Q1 		$242K Sell
4,274
-1,257
-23% -$65.6K 0.04% 595
2021
Q4 		$287K Buy
+5,531
New +$285K 0.09% 259
2021
Q2 		– Sell
-4,689
Closed -$305K – 472
2021
Q1 		$305K Buy
+4,689
New +$306K 0.07% 349
2019
Q1 		– Sell
-12,193
Closed -$598K – 603
2018
Q4 		$598K Sell
12,193
-23,506
-66% -$1.34M 0.12% 245
2018
Q3 		$2.21M Buy
35,699
+31,425
+735% +$1.91M 0.36% 66
2018
Q2 		$230K Buy
+4,274
New +$214K 0.05% 484
2018
Q1 		– Sell
-7,165
Closed -$282K – 640
2017
Q4 		$282K Sell
7,165
-14,204
-66% -$540K 0.06% 426
2017
Q3 		$788K Buy
21,369
+2,263
+12% +$80.6K 0.19% 171
2017
Q2 		$736K Buy
+19,106
New +$700K 0.27% 125
2017
Q1 		– Sell
-24,760
Closed -$812K – 482
2016
Q4 		$812K Buy
24,760
+11,941
+93% +$387K 0.2% 184
2016
Q3 		$414K Sell
12,819
-2,981
-19% -$96.6K 0.27% 131
2016
Q2 		$488K Buy
15,800
+7,164
+83% +$224K 0.29% 122
2016
Q1 		$259K Buy
+8,636
New +$238K 0.24% 199

Other funds holding EHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bayesian Capital Management's EHC Position: Q4 2025 in Review

Bayesian Capital Management sold out of Encompass Health (EHC) in Q4 2025, closing a stake of 3,635 shares — an estimated $462K sold.

Bayesian Capital Management first reported a position in EHC in Q1 2016 and held it in 20 quarters. The position peaked at $2.51M in Q2 2025. 594 funds tracked by Wall St. Rank hold EHC as of Q4 2025.

  • Bayesian Capital Management reported no remaining Encompass Health position as of Q4 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 3,635 Encompass Health shares in Q4 2025, an estimated $462K.
  • Bayesian Capital Management first reported a position in Encompass Health in Q1 2016 and held it in 20 quarters.
  • Bayesian Capital Management's Encompass Health position peaked at $2.51M in Q2 2025.
  • 594 funds tracked by Wall St. Rank held Encompass Health as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.